Springer Nature
Browse
12931_2021_1921_MOESM1_ESM.docx (44.79 kB)

Additional file 1 of Associations between resources and practices of ILD centers and outcomes in patients with idiopathic pulmonary fibrosis: data from the IPF-PRO Registry

Download (44.79 kB)
journal contribution
posted on 2022-01-08, 04:26 authored by Joao A. de Andrade, Tejaswini Kulkarni, Megan L. Neely, Anne S. Hellkamp, Amy Hajari Case, Daniel A. Culver, Kalpalatha Guntupalli, Shaun Bender, Craig S. Conoscenti, Laurie D. Snyder
Additional file 1: Appendix S1. Identification of predictors of clinical outcomes used in adjustment of models. Table S1. Baseline characteristics of patients enrolled at sites included versus not included in the analysis. Table S2. Responses to questionnaire from sites that enrolled < 25 versus ≥ 25 patients. Table S3. Responses to questionnaire from sites with versus without an ILD-related quality improvement project.

Funding

The IPF-PRO/ILD-PRO™ Registry is funded by Boehringer Ingelheim Pharmaceuticals, Inc. (BIPI) and co-ordinated by the Duke Clinical Research Institute (DCRI).

History